KCM
EVH icon

Kornitzer Capital Management’s Evolent Health EVH Stock Holding History

Kornitzer Capital Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,600
Closed -$851K – 516
2025
Q3 		$851K Hold
100,600
– – 0.02% 424
2025
Q2 		$1.13M Buy
+100,600
New +$924K 0.02% 378
2023
Q3 		– Sell
-311,966
Closed -$9.45M – 488
2023
Q2 		$9.45M Sell
311,966
-237,105
-43% -$7.67M 0.19% 180
2023
Q1 		$17.8M Sell
549,071
-184,285
-25% -$5.83M 0.36% 76
2022
Q4 		$20.6M Buy
733,356
+161,050
+28% +$4.62M 0.42% 59
2022
Q3 		$20.6M Buy
572,306
+36,221
+7% +$1.28M 0.44% 58
2022
Q2 		$16.5M Hold
536,085
– – 0.33% 81
2022
Q1 		$17.3M Hold
536,085
– – 0.29% 117
2021
Q4 		$14.8M Buy
+536,085
New +$15.4M 0.22% 176
2018
Q3 		– Sell
-1,130,880
Closed -$23.8M – 478
2018
Q2 		$23.8M Sell
1,130,880
-152,125
-12% -$2.88M 0.4% 97
2018
Q1 		$18.3M Buy
1,283,005
+276,640
+27% +$3.96M 0.31% 113
2017
Q4 		$12.4M Buy
1,006,365
+205,360
+26% +$2.89M 0.21% 145
2017
Q3 		$14.3M Buy
+801,005
New +$16.5M 0.25% 126

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kornitzer Capital Management's EVH Position: Q4 2025 in Review

Kornitzer Capital Management sold out of Evolent Health (EVH) in Q4 2025, closing a stake of 100,600 shares — an estimated $851K sold.

Kornitzer Capital Management first reported a position in EVH in Q3 2017 and held it in 13 quarters. The position peaked at $23.8M in Q2 2018. 215 funds tracked by Wall St. Rank hold EVH as of Q4 2025.

  • Kornitzer Capital Management reported no remaining Evolent Health position as of Q4 2025 after selling out during the quarter.
  • Kornitzer Capital Management sold 100,600 Evolent Health shares in Q4 2025, an estimated $851K.
  • Kornitzer Capital Management first reported a position in Evolent Health in Q3 2017 and held it in 13 quarters.
  • Kornitzer Capital Management's Evolent Health position peaked at $23.8M in Q2 2018.
  • 215 funds tracked by Wall St. Rank held Evolent Health as of Q4 2025.

Based on Kornitzer Capital Management's 13F filing for Q4 2025, filed 2 Feb 2026.